Business Description
Embla Medical hf
ISIN : IS0000000040
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.77 | |||||
Debt-to-EBITDA | 3.86 | |||||
Interest Coverage | 4.5 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.77 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.9 | |||||
3-Year EBITDA Growth Rate | 23 | |||||
3-Year EPS without NRI Growth Rate | 119.9 | |||||
3-Year FCF Growth Rate | -5 | |||||
3-Year Book Growth Rate | 11.2 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.68 | |||||
Quick Ratio | 1.07 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 164.05 | |||||
Days Sales Outstanding | 56.2 | |||||
Days Payable | 35.78 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -0.69 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.42 | |||||
Operating Margin % | 10.94 | |||||
Net Margin % | 7.08 | |||||
FCF Margin % | 5.82 | |||||
ROE % | 8.31 | |||||
ROA % | 4.09 | |||||
ROIC % | 5.34 | |||||
ROC (Joel Greenblatt) % | 27.93 | |||||
ROCE % | 7.87 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 29.89 | |||||
PE Ratio without NRI | 29.89 | |||||
Shiller PE Ratio | 26.24 | |||||
Price-to-Owner-Earnings | 23.82 | |||||
PEG Ratio | 10.31 | |||||
PS Ratio | 2.14 | |||||
PB Ratio | 2.36 | |||||
Price-to-Free-Cash-Flow | 36.77 | |||||
Price-to-Operating-Cash-Flow | 18.52 | |||||
EV-to-EBIT | 23.69 | |||||
EV-to-EBITDA | 15.31 | |||||
EV-to-Revenue | 2.75 | |||||
EV-to-FCF | 47.19 | |||||
Price-to-Projected-FCF | 1.57 | |||||
Price-to-DCF (Earnings Based) | 1.85 | |||||
Price-to-DCF (FCF Based) | 2.28 | |||||
Price-to-Median-PS-Value | 0.63 | |||||
Earnings Yield (Greenblatt) % | 4.22 | |||||
FCF Yield % | 2.72 | |||||
Forward Rate of Return (Yacktman) % | 5.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Embla Medical hf Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 5,539.344 | ||
EPS (TTM) (kr) | 0.93 | ||
Beta | 0.56 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (kr) | 0 | ||
20-Day SMA (kr) | 30.9 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (kr) | 30.9 - 30.9 | ||
Shares Outstanding (Mil) | 426.93 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Embla Medical hf Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Embla Medical hf Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Embla Medical hf Frequently Asked Questions
What is Embla Medical hf(CHIX:EMBLAc)'s stock price today?
When is next earnings date of Embla Medical hf(CHIX:EMBLAc)?
Does Embla Medical hf(CHIX:EMBLAc) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |